Drug recall · January 11, 2023
Heparin Sodium 2 recall
Why: Lack of assurance of sterility: Bags have the potential to leak.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,
- Lots / codes
Lot: 5935283, Exp. 12/01/2023
- Quantity
- 62,088 bags
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the USA.
- Initiated
- December 29, 2022 · Voluntary: Firm initiated
- Classified
- January 5, 2023
- Reported
- January 11, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.